Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Lonsurf

Active ingredient: Trifluridine Tipiracil

Neutral reference profile for an independent medicine-access consultancy enquiry about Lonsurf (Trifluridine Tipiracil). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Lonsurf used for?

Lonsurf (trifluridine/tipiracil) is a chemotherapy indicated for the treatment of people with advanced (metastatic) colorectal cancer who have been previously treated with chemotherapy and biological therapy.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Lonsurf identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordLonsurf
Active ingredientTrifluridine Tipiracil
Dosage formfilm-coated tablets
Recorded options4
Directory areaOncology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 15 mg/6.14 mg · 20 tablets Catalogue organisation: SERVIER Deutschland GmbH
  2. 15 mg/6.14 mg film-coated tablets · 60 tablets Catalogue organisation: EurimPharm Arzneimittel GmbH
  3. 20 mg/8.19 mg · 20 tablets Catalogue organisation: SERVIER Deutschland GmbH
  4. 20 mg/8.19 mg film-coated tablets · 60 tablets Catalogue organisation: axicorp Pharma B.V.

OFFICIAL SOURCES

Check the Lonsurf record at an official source.

Search for “Lonsurf” or “Trifluridine Tipiracil”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.

SERVICE BOUNDARY

Information checking and independent enquiry support for Lonsurf.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Lonsurf

01What is Lonsurf?

This directory record associates the brand name Lonsurf with the active ingredient Trifluridine Tipiracil. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Lonsurf strengths and packs are recorded?

The catalogue currently shows: 15 mg/6.14 mg · 20 tablets; 15 mg/6.14 mg film-coated tablets · 60 tablets; 20 mg/8.19 mg · 20 tablets; 20 mg/8.19 mg film-coated tablets · 60 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Lonsurf?

Catalogue records currently name: SERVIER Deutschland GmbH, EurimPharm Arzneimittel GmbH, axicorp Pharma B.V.. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Lonsurf?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Lonsurf, payment request, stock guarantee or binding offer.

06Can I buy Lonsurf from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.